文献速递胸部外周血管MRCT

有症状的新冠急性后综合征患者中持续存在的129Xe MRI肺部异常与CT血管异常

Persistent 129Xe MRI Pulmonary and CT Vascular Abnormalities in Symptomatic Individuals with Post-acute COVID-19 Syndrome.
PubMed 文献 · Radiology · 2022-06-28

这项前瞻性研究纳入34例新冠急性后综合征(PACS)患者和6名健康对照, evaluate 129Xe MRI红细胞/肺泡屏障信号比与CT肺血管密度(BV5)等指标及其与症状、运动受限的关系。既往住院的PACS患者129Xe MRI红细胞/屏障比值低于对照(P=.04),BV5与红细胞AUC相关(ρ=.44,P=.03),129Xe MRI指标与DLco、FEV1、呼吸困难及运动能力相关。

要点

  • 既往住院的PACS患者129Xe MRI红细胞/屏障比值低于健康对照(P=.04)。
  • CT肺血管密度BV5与129Xe MRI红细胞AUC相关(ρ=.44,P=.03)。
  • 129Xe MRI红细胞/屏障比值与DLco(r=.57,P=.002)及FEV1(ρ=.35,P=.03)相关。

核心结论

  • 既往因新冠住院的PACS患者在感染后34周±25天时129Xe MRI测量值低于对照,且129Xe MRI指标与CT肺血管密度、DLco、运动能力和呼吸困难相关。

研究设计与样本

  • 前瞻性研究,2021年4月至10月从四级诊疗新冠门诊招募18-80岁PCR阳性PACS患者34例(其中22例从未住院)及无新冠史的对照6例,行肺功能、DLco、129Xe MRI和胸部CT。

诊断标准与关键数值

  • 129Xe MRI红细胞/肺泡屏障信号比在既往住院的PACS患者中低于对照(P=.04)。
  • CT测量横截面积≤5 mm²的肺血管体积(BV5)与129Xe MRI红细胞AUC相关(ρ=.44,P=.03)。
  • 129Xe MRI红细胞/屏障比与DLco相关(r=.57,P=.002),与FEV1相关(ρ=.35,P=.03)。
  • 129Xe MRI红细胞AUC与呼吸困难相关(ρ=-.35,P=.04),与国际体力活动问卷评分相关(ρ=.45,P=.02)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND: In patients with post-acute COVID-19 syndrome (PACS), abnormal gas-transfer and pulmonary vascular density have been reported, but such findings have not been related to each other or to symptoms and exercise limitation. The pathophysiologic drivers of PACS in patients previously infected with COVID-19 who were admitted to in-patient treatment in hospital (or ever-hospitalized patients) and never-hospitalized patients are not well understood.

PURPOSE: To determine the relationship of persistent symptoms and exercise limitation with xenon 129 (129Xe) MRI and CT pulmonary vascular measurements in individuals with PACS.

MATERIALS AND METHODS: In this prospective study, patients with PACS aged 18-80 years with a positive polymerase chain reaction COVID-19 test were recruited from a quaternary-care COVID-19 clinic between April and October 2021. Participants with PACS underwent spirometry, diffusing capacity of the lung for carbon monoxide (DLco), 129Xe MRI, and chest CT. Healthy controls had no prior history of COVID-19 and underwent spirometry, DLco, and 129Xe MRI. The 129Xe MRI red blood cell (RBC) to alveolar-barrier signal ratio, RBC area under the receiver operating characteristic curve (AUC), CT volume of pulmonary vessels with cross-sectional area 5 mm2 or smaller (BV5), and total blood volume were quantified. St George's Respiratory Questionnaire, International Physical Activity Questionnaire, and modified Borg Dyspnea Scale measured quality of life, exercise limitation, and dyspnea. Differences between groups were compared with use of Welch t-tests or Welch analysis of variance. Relationships were evaluated with use of Pearson (r) and Spearman (ρ) correlations.

RESULTS: Forty participants were evaluated, including six controls (mean age ± SD, 35 years ± 15, three women) and 34 participants with PACS (mean age, 53 years ± 13, 18 women), of whom 22 were never hospitalized. The 129Xe MRI RBC:barrier ratio was lower in ever-hospitalized participants (P = .04) compared to controls. BV5 correlated with RBC AUC (ρ = .44, P = .03). The 129Xe MRI RBC:barrier ratio was related to DLco (r = .57, P = .002) and forced expiratory volume in 1 second (ρ = .35, P = .03); RBC AUC was related to dyspnea (ρ = -.35, P = .04) and International Physical Activity Questionnaire score (ρ = .45, P = .02).

CONCLUSION: Xenon 129 (129Xe) MRI measurements were lower in participants previously infected with COVID-19 who were admitted to in-patient treatment in hospital with post-acute COVID-19 syndrome, 34 weeks ± 25 after infection compared to controls. The 129Xe MRI measures were associated with CT pulmonary vascular density, diffusing capacity of the lung for carbon monoxide, exercise capacity, and dyspnea. Clinical trial registration no.: NCT04584671 © RSNA, 2022 Online supplemental material is available for this article See also the editorial by Wild and Collier in this issue.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Matheson, McIntosh, Kooner, et al. Persistent 129Xe MRI Pulmonary and CT Vascular Abnormalities in Symptomatic Individuals with Post-acute COVID-19 Syndrome. Radiology. 2022. PMID: 35762891. doi:10.1148/radiol.220492

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。